
The global circRNA Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The circRNA does not have a 5'-end cap or a 3'-end poly(A) tail. Through exon circularization or intron circularization, the 3'- and 5'-ends are connected to form a complete circular structure to avoid being degraded by exoribonucleases, making it more stable and conserved than linear RNA. Circular RNA plays a key role in diseases, especially cancer, and has unique advantages in disease diagnosis and the development of therapeutic strategies.The potential of circRNA and the enthusiasm of the market indicate its bright future, but there are still some challenges. For example, how to precisely regulate the expression level of circRNA to maintain it at an appropriate functional level without overexpression leading to toxicity requires further development; more in-depth research is needed on circRNA modification to further reduce the immunogenicity of circRNA. At the same time, delivery is also one of the main challenges for various applications. It is believed that with the continuous advancement of scientific research and technology, the continuous improvement of circRNA technology will help it enter the industrialization stage more widely.
North American market for circRNA Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for circRNA Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for circRNA Technology in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of circRNA Technology include Orna Therapeutics, Sail Biomedicines, Therorna Inc., CirCode Bio, Abogen Biosciences, SuZhou CureMed Biomedical Technology Co, Guangzhou Geneseed Biotech. Co., Ltd., Rznomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for circRNA Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding circRNA Technology.
The circRNA Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global circRNA Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the circRNA Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Orna Therapeutics
Sail Biomedicines
Therorna Inc.
CirCode Bio
Abogen Biosciences
SuZhou CureMed Biomedical Technology Co
Guangzhou Geneseed Biotech. Co., Ltd.
Rznomics
Segment by Type
circRNA Synthesis
Drug Delivery
Other
Segment by Application
Gene Therapy
Drug Delivery
Vaccine Delivery
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of circRNA Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global circRNA Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 circRNA Synthesis
1.2.3 Drug Delivery
1.2.4 Other
1.3 Market by Application
1.3.1 Global circRNA Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Drug Delivery
1.3.4 Vaccine Delivery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global circRNA Technology Market Perspective (2019-2030)
2.2 Global circRNA Technology Growth Trends by Region
2.2.1 Global circRNA Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 circRNA Technology Historic Market Size by Region (2019-2024)
2.2.3 circRNA Technology Forecasted Market Size by Region (2025-2030)
2.3 circRNA Technology Market Dynamics
2.3.1 circRNA Technology Industry Trends
2.3.2 circRNA Technology Market Drivers
2.3.3 circRNA Technology Market Challenges
2.3.4 circRNA Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top circRNA Technology Players by Revenue
3.1.1 Global Top circRNA Technology Players by Revenue (2019-2024)
3.1.2 Global circRNA Technology Revenue Market Share by Players (2019-2024)
3.2 Global circRNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by circRNA Technology Revenue
3.4 Global circRNA Technology Market Concentration Ratio
3.4.1 Global circRNA Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by circRNA Technology Revenue in 2023
3.5 Global Key Players of circRNA Technology Head office and Area Served
3.6 Global Key Players of circRNA Technology, Product and Application
3.7 Global Key Players of circRNA Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 circRNA Technology Breakdown Data by Type
4.1 Global circRNA Technology Historic Market Size by Type (2019-2024)
4.2 Global circRNA Technology Forecasted Market Size by Type (2025-2030)
5 circRNA Technology Breakdown Data by Application
5.1 Global circRNA Technology Historic Market Size by Application (2019-2024)
5.2 Global circRNA Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America circRNA Technology Market Size (2019-2030)
6.2 North America circRNA Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America circRNA Technology Market Size by Country (2019-2024)
6.4 North America circRNA Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe circRNA Technology Market Size (2019-2030)
7.2 Europe circRNA Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe circRNA Technology Market Size by Country (2019-2024)
7.4 Europe circRNA Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific circRNA Technology Market Size (2019-2030)
8.2 Asia-Pacific circRNA Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific circRNA Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific circRNA Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America circRNA Technology Market Size (2019-2030)
9.2 Latin America circRNA Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America circRNA Technology Market Size by Country (2019-2024)
9.4 Latin America circRNA Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa circRNA Technology Market Size (2019-2030)
10.2 Middle East & Africa circRNA Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa circRNA Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa circRNA Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Orna Therapeutics
11.1.1 Orna Therapeutics Company Details
11.1.2 Orna Therapeutics Business Overview
11.1.3 Orna Therapeutics circRNA Technology Introduction
11.1.4 Orna Therapeutics Revenue in circRNA Technology Business (2019-2024)
11.1.5 Orna Therapeutics Recent Development
11.2 Sail Biomedicines
11.2.1 Sail Biomedicines Company Details
11.2.2 Sail Biomedicines Business Overview
11.2.3 Sail Biomedicines circRNA Technology Introduction
11.2.4 Sail Biomedicines Revenue in circRNA Technology Business (2019-2024)
11.2.5 Sail Biomedicines Recent Development
11.3 Therorna Inc.
11.3.1 Therorna Inc. Company Details
11.3.2 Therorna Inc. Business Overview
11.3.3 Therorna Inc. circRNA Technology Introduction
11.3.4 Therorna Inc. Revenue in circRNA Technology Business (2019-2024)
11.3.5 Therorna Inc. Recent Development
11.4 CirCode Bio
11.4.1 CirCode Bio Company Details
11.4.2 CirCode Bio Business Overview
11.4.3 CirCode Bio circRNA Technology Introduction
11.4.4 CirCode Bio Revenue in circRNA Technology Business (2019-2024)
11.4.5 CirCode Bio Recent Development
11.5 Abogen Biosciences
11.5.1 Abogen Biosciences Company Details
11.5.2 Abogen Biosciences Business Overview
11.5.3 Abogen Biosciences circRNA Technology Introduction
11.5.4 Abogen Biosciences Revenue in circRNA Technology Business (2019-2024)
11.5.5 Abogen Biosciences Recent Development
11.6 SuZhou CureMed Biomedical Technology Co
11.6.1 SuZhou CureMed Biomedical Technology Co Company Details
11.6.2 SuZhou CureMed Biomedical Technology Co Business Overview
11.6.3 SuZhou CureMed Biomedical Technology Co circRNA Technology Introduction
11.6.4 SuZhou CureMed Biomedical Technology Co Revenue in circRNA Technology Business (2019-2024)
11.6.5 SuZhou CureMed Biomedical Technology Co Recent Development
11.7 Guangzhou Geneseed Biotech. Co., Ltd.
11.7.1 Guangzhou Geneseed Biotech. Co., Ltd. Company Details
11.7.2 Guangzhou Geneseed Biotech. Co., Ltd. Business Overview
11.7.3 Guangzhou Geneseed Biotech. Co., Ltd. circRNA Technology Introduction
11.7.4 Guangzhou Geneseed Biotech. Co., Ltd. Revenue in circRNA Technology Business (2019-2024)
11.7.5 Guangzhou Geneseed Biotech. Co., Ltd. Recent Development
11.8 Rznomics
11.8.1 Rznomics Company Details
11.8.2 Rznomics Business Overview
11.8.3 Rznomics circRNA Technology Introduction
11.8.4 Rznomics Revenue in circRNA Technology Business (2019-2024)
11.8.5 Rznomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Orna Therapeutics
Sail Biomedicines
Therorna Inc.
CirCode Bio
Abogen Biosciences
SuZhou CureMed Biomedical Technology Co
Guangzhou Geneseed Biotech. Co., Ltd.
Rznomics
Ìý
Ìý
*If Applicable.
